QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function 期刊论文 CELL RESEARCH, 2021, 页码: 18 作者:  Xu, Xiang;  Ding, Guangjin;  Liu, Caizhi;  Ding, Yuhan;  Chen, Xiaoxin 收藏  |  浏览/下载：63/0  |  提交时间：2021/11/04 The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability 期刊论文 MOLECULAR CELL, 2021, 卷号: 81, 期号: 13, 页码: 2736-+ 作者:  Pan, Qiang;  Zhong, Shanshan;  Wang, Hanling;  Wang, Xuege;  Li, Ni 收藏  |  浏览/下载：74/0  |  提交时间：2021/11/04 Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation 期刊论文 MOLECULAR MEDICINE REPORTS, 2021, 卷号: 23, 期号: 5, 页码: 12 作者:  Huang, He-Ming;  Zhou, Xiao-Ru;  Liu, Yan-Jun;  Fan, Shi-Jie;  Liao, Li-Ping 收藏  |  浏览/下载：46/0  |  提交时间：2021/05/24 liver fibrosis  hepatic stellate cell  histone deacetylase inhibitor  epigenetics  givinostat   P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Zhou, Xiao-ru;  Li, Xiao;  Liao, Li-ping;  Han, Jie;  Huang, Jing 收藏  |  浏览/下载：30/0  |  提交时间：2021/06/11 mantle cell lymphoma  idelalisib  drug resistance  P300  CBP  synergistic drug action  PI3Kδ  epigenetics   P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Zhou, Xiao-ru;  Li, Xiao;  Liao, Li-ping;  Han, Jie;  Huang, Jing 收藏  |  浏览/下载：27/0  |  提交时间：2021/06/11 mantle cell lymphoma  idelalisib  drug resistance  P300  CBP  synergistic drug action  PI3Kδ  epigenetics   Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 209, 页码: 20 作者:  Chen, Jingjing;  Li, Yalei;  Zhang, Jie;  Zhang, Minmin;  Wei, Aihuan 收藏  |  浏览/下载：26/0  |  提交时间：2021/05/24 HDAC  BRD4  Selective dual inhibitors  Anticancer   PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma 期刊论文 THERANOSTICS, 2021, 卷号: 11, 期号: 11, 页码: 5387-5403 作者:  Wang, Jianfeng;  Wang, Chen;  Xu, Pan;  Li, Xiao;  Lu, Yongning 收藏  |  浏览/下载：129/0  |  提交时间：2021/05/24 clear cell renal cell carcinoma  protein arginine methyltransferase 1  therapeutic  lipocalin2 (LCN2)  sunitinib